<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1729-519X</journal-id>
<journal-title><![CDATA[Revista Habanera de Ciencias Médicas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev haban cienc méd]]></abbrev-journal-title>
<issn>1729-519X</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de la Habana]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1729-519X2021000100017</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome amotivacional en consumidores crónicos de marihuana. Una revisión narrativa para la aproximación al concepto]]></article-title>
<article-title xml:lang="en"><![CDATA[Amotivational syndrome in chronic marijuana users. A narrative review to approach the concept]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castaño Pérez]]></surname>
<given-names><![CDATA[Guillermo A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Becoña Iglesias]]></surname>
<given-names><![CDATA[Elisardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Scoppetta DG]]></surname>
<given-names><![CDATA[Orlando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Restrepo Escobar]]></surname>
<given-names><![CDATA[Sandra Milena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad CES  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Santiago de Compostela  ]]></institution>
<addr-line><![CDATA[La Coruña ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Católica de Colombia  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Católica Luis Amigó  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2021</year>
</pub-date>
<volume>20</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1729-519X2021000100017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1729-519X2021000100017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1729-519X2021000100017&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  Durante los últimos sesenta años se ha construido evidencia sobre los efectos adversos relacionados con el consumo crónico de cannabis. Los problemas de memoria y concentración, el riesgo de esquizofrenia en sujetos predispuestos y el síndrome amotivacional han sido referenciados. Con los primeros al parecer no hay muchas dudas, pero en relación con el último, existe controversia.  Objetivo:  revisar la evidencia científica existente sobre el síndrome amotivacional.  Material y Métodos:  La revisión se realizó mediante una búsqueda en bases de datos académicas, se tomaron en cuenta las publicaciones que estuvieran relacionadas con trastornos mentales relacionados con el consumo crónico de marihuana en los que se hacía referencia al síndrome amotivacional que cumplieran con criterios de calidad de los artículos apegados a estándares internacionales.  Desarrollo:  Se incluyó un total de 31 artículos, de los cuales 16 incluían la definición de síndrome amotivacional. Una vez integradas todas las fuentes, se determinó organizar la evidencia encontrada en 15 factores: apatía; desinterés; pasividad; indiferencia; demora en la realización de tareas; pereza; presentismo; desgano para actividades prolongadas que requieran atención o tenacidad; abandono del cuidado personal; desinterés sexual; disminución de los reflejos; autoeficacia disminuida; deterioro de las habilidades comunicativas; retraimiento social y afecto no alterado.  Conclusiones:  A partir de los hallazgos, se sugiere que el síndrome amotivacional es una constelación de síntomas y/o signos relacionados, lo que podría constituir una morbilidad propia del consumo crónico de cannabis, se espera que en el futuro se desarrollen investigaciones que prueben o rechacen su existencia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Over the past sixty years, evidence for the adverse effects of chronic cannabis use has been demonstrated. Memory and concentration problems, the risk of schizophrenia in predisposed subjects, and amotivational syndrome have been referenced. There is not much doubt in relation to the first effect mentioned, but there is controversy around the last.  Objective:  To review the existing scientific evidence for the amotivational syndrome.  Material and Methods:  The review was conducted through academic database searching. The publications related to mental disorders associated with the chronic marijuana use, which referred to amotivational syndrome that fulfilled the criteria for articles attached to international standards, were taken into account.  Results:  A total of 31 articles were included. Of them, 16 presented the definition of amotivational syndrome. Once all the sources were integrated, the evidence found in 15 factors was organized. These factors included: apathy; disinterest; passivity; indifference; delay to perform tasks; sloth; presentism; reluctance to do prolonged activities that require attention or tenacity; abandonment of personal care; sexual disinterest; decreased reflexes; decreased self-efficacy; impairment in communication skills; social withdrawal, and unaltered affection.  Conclusions:  Based on these findings, we suggest that the amotivational syndrome is a constellation of symptoms and / or related signs which could constitute a typical morbidity caused by chronic cannabis use, so we expect that future research will be developed to demonstrate or discard their existence.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[cannabis]]></kwd>
<kwd lng="es"><![CDATA[síndrome amotivacional]]></kwd>
<kwd lng="es"><![CDATA[consumo crónico]]></kwd>
<kwd lng="es"><![CDATA[concepto]]></kwd>
<kwd lng="en"><![CDATA[cannabis]]></kwd>
<kwd lng="en"><![CDATA[amotivational syndrome]]></kwd>
<kwd lng="en"><![CDATA[chronic consumption]]></kwd>
<kwd lng="en"><![CDATA[concept]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Budney]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Borodovky]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Knapp]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical manifestations of Cannabis use disorder]]></article-title>
<source><![CDATA[Cannabis use Disorders]]></source>
<year>2019</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abarca Villalobos]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Flores Sandí]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso terapéutico de cannabinoides bajo prescripción médica]]></article-title>
<source><![CDATA[Acta Médica Costarric]]></source>
<year>2007</year>
<volume>49</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>114-7</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud</collab>
<source><![CDATA[La marihuana con uso terapéutico en el contexto colombiano. Gobierno apoya discusión en el congreso sobre uso terapéutico de marihuana]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morales Basto]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Poveda Espinosa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos del consumo de marihuana en adultos sobre la ingesta y el metabolismo de los nutrientes una revisión]]></article-title>
<source><![CDATA[Revista Española de Nutrición Humana y Dietética]]></source>
<year>2017</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>280-92</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>National Institute on Drug Abuse</collab>
<source><![CDATA[Abuso de la Marihuana]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Estados Unidos ]]></publisher-loc>
<publisher-name><![CDATA[National Institute on Drug Abuse]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tziraki]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trastornos mentales y afectación neuropsicológica relacionados con el uso crónico de cannabis]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2012</year>
<volume>54</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>750-60</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montoya]]></surname>
<given-names><![CDATA[ID]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[SRB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Introduction to Cannabis Use Disorders]]></article-title>
<source><![CDATA[Cannabis Use Disorders]]></source>
<year>2019</year>
<publisher-loc><![CDATA[New york ]]></publisher-loc>
<publisher-name><![CDATA[Springer Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brutlag]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hommerding]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats]]></article-title>
<source><![CDATA[Veterinary Clinics: Small Animal Practice]]></source>
<year>2018</year>
<volume>48</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1087-102</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granados]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exploración psicométrica sobre deficiencia motivacional en consumidores de marihuana Interdisciplinaria]]></article-title>
<source><![CDATA[Revista de Psicología y Ciencias Afines]]></source>
<year>2020</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Köguel]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Constituyentes psicoactivos del cannabis y sus implicaciones clínicas una revisión sistemática]]></article-title>
<source><![CDATA[Adicciones]]></source>
<year>2018</year>
<volume>30</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>140-51</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute and chronic toxicity of marijuana]]></article-title>
<source><![CDATA[J Psychodel Drug]]></source>
<year>1968</year>
<volume>2</volume>
<page-range>37-47</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wiesbeck]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Schuckit]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kalmijn]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Tipp]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Bucholz]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An Evaluation of the History of a Marijuana Withdrawal Syndrome in a Large Population]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>1996</year>
<volume>91</volume>
<page-range>1469-78</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vélez]]></surname>
<given-names><![CDATA[MMS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trastornos causados por el consumo de sustancias derivadas del cannabis]]></article-title>
<source><![CDATA[RECIAMUC]]></source>
<year>2019</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1486-502</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabin]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of extended cannabis abstinence on cognitive outcomes in cannabis dependent patients with schizophrenia vs non-psychiatric controls]]></article-title>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>2017</year>
<volume>42</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2259-71</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calderón Peña]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[El consumo de cannabis: bases neurológicas y perspectiva sociológica]]></source>
<year>2017</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Cantabria]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis and epilepsy an ancient treatment returns to the fore]]></article-title>
<source><![CDATA[Epilepsy &amp; Behavior]]></source>
<year>2017</year>
<volume>70</volume>
<page-range>292-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McGlothlin]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[West]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The marihuana problem an overview]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1968</year>
<volume>125</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>126-34</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blomfield]]></surname>
<given-names><![CDATA[MAP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of? 9-tetrahydrocannabinol on the dopamine system]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2016</year>
<volume>539</volume>
<numero>7629</numero>
<issue>7629</issue>
<page-range>369-77</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manzanares]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Urigüen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rubio]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Palomo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of endocannabinoid system in mental diseases]]></article-title>
<source><![CDATA[Neurotox Res]]></source>
<year>2004</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>213-24</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beeder]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Millman]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of patients with psychopathology and substance abuse]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Lowinson]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Millman]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Langrod]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<source><![CDATA[Substance abuse: A comprebensive textbook]]></source>
<year>1997</year>
<edition>3</edition>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
<publisher-name><![CDATA[Williams &amp; Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pope]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Yurgelun Todd]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Residual Cognitive Effects of Heavy Marijuana Use in College Students]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1996</year>
<volume>275</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>521-7</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheier]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Griffin]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Youth marijuana use: a review of causes and consequences]]></article-title>
<source><![CDATA[Current Opinion in Psychology]]></source>
<year>2020</year>
<volume>38</volume>
<page-range>11-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jessor]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jessor]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Finney]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marijuana Use in High School and College]]></article-title>
<source><![CDATA[Problem Behavior Theory and Adolescent Health]]></source>
<year>2017</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Worner]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
</person-group>
<source><![CDATA[Assessing a bystander intervention program for first-year students at the University of Wisconsin-La Crosse]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Estados Unidos ]]></publisher-loc>
<publisher-name><![CDATA[University of Wisconsin-La Crosse]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Lalonde]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Tormohlen]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marijuana use, craving, and academic motivation and performance among college students An in-the-moment study]]></article-title>
<source><![CDATA[Addict Behav]]></source>
<year>2015</year>
<volume>47</volume>
<page-range>42-7</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suerken]]></surname>
<given-names><![CDATA[CKl]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marijuana use trajectories and academic outcomes among college students]]></article-title>
<source><![CDATA[Drug and Alcohol Dependence]]></source>
<year>2016</year>
<volume>162</volume>
<page-range>137-45</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawn]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning an evaluation of the cannabis 'amotivational'hypotheses]]></article-title>
<source><![CDATA[Psychopharmacology]]></source>
<year>2016</year>
<volume>233</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>3537-52</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood]]></article-title>
<source><![CDATA[Journal of Psychopharmacology]]></source>
<year>2020</year>
<volume>34</volume>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnwell]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Earleywine]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wilcox]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis, motivation, and life satisfaction in an internet sample]]></article-title>
<source><![CDATA[Subst Abuse Treat Prev Policy]]></source>
<year>2006</year>
<volume>1</volume>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petrucci]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[LaFrance]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Cuttler]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Comprehensive Examination of the Links between Cannabis Use and Motivation]]></article-title>
<source><![CDATA[Substance Use &amp; Misuse]]></source>
<year>2020</year>
<volume>55</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1155-64</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lanctôt]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apathy associated with neurocognitive disorders recent progress and future directions]]></article-title>
<source><![CDATA[Alzheimer&amp;apos;s &amp; Dementia]]></source>
<year>2017</year>
<volume>13</volume>
<page-range>84-100</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apathy Concept, Syndrome, Neural Mechanisms, and Treatment]]></article-title>
<source><![CDATA[Semin Clin Neuropsychiatry]]></source>
<year>1996</year>
<volume>1</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>304-14</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marin]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differential diagnosis and classification of apathy]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1990</year>
<volume>147</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-30</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ducharme]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Dickerson]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apathy a neurocircuitry model based on frontotemporal dementia]]></article-title>
<source><![CDATA[Journal of Neurology Neurosurgery &amp; Psychiatry]]></source>
<year>2018</year>
<volume>89</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>389-96</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuropsychological correlates of cognitive, emotional-affective and auto-activation apathy in Alzheimer&amp;apos;s disease]]></article-title>
<source><![CDATA[Neuropsychologia]]></source>
<year>2018</year>
<volume>118</volume>
<page-range>12-21</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eslinger]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Damasio]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe disturbance of higher cognition after bilateral frontal lobe ablation patient EVR]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>1985</year>
<volume>35</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1731-41</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martens]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[SJG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathology of behavior in PD What is known and what is not?.]]></article-title>
<source><![CDATA[Journal Neurological Sciences]]></source>
<year>2017</year>
<volume>374</volume>
<page-range>9-16</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bolla]]></surname>
<given-names><![CDATA[KI]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Eldreth]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Tate]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Cadet]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dose-related neurocognitive effects of marijuana use]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2002</year>
<volume>59</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1337-43</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verdejo Garcia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Benbrook]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Funderburk]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[David]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cadet]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Bolla]]></surname>
<given-names><![CDATA[KI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task]]></article-title>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>2007</year>
<volume>90</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2-11</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wylie]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroanatomy: The brain-behavior relationship]]></article-title>
<source><![CDATA[Changes in the Brain]]></source>
<year>2017</year>
<page-range>1-21</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cummings]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apathy in neurodegenerative diseases recommendations on the design of clinical trials]]></article-title>
<source><![CDATA[Journal Geriatric Psychiatry Neurology]]></source>
<year>2015</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>159-73</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camargo]]></surname>
<given-names><![CDATA[CHF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differentiating between apathy and depression in patients with parkinson disease dementia]]></article-title>
<source><![CDATA[American Journal of Alzheimer&amp;apos;s Disease &amp; Other Dementias]]></source>
<year>2018</year>
<volume>33</volume>
<page-range>30-4</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bovasso]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis abuse as a risk factor for depressive symptoms]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>2001</year>
<volume>158</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2033-7</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Anthony]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey]]></article-title>
<source><![CDATA[Soc Psychiatry Psychiatr Epidemiol]]></source>
<year>2002</year>
<volume>37</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>199-206</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanna]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ghose]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis and development of dual diagnoses a literature review]]></article-title>
<source><![CDATA[The American Journal of Drug and Alcohol Abuse]]></source>
<year>2017</year>
<volume>43</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>442-55</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[THM]]></given-names>
</name>
<name>
<surname><![CDATA[Zammit]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lingford Hughes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[TRE]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2007</year>
<volume>370</volume>
<numero>9584</numero>
<issue>9584</issue>
<page-range>319-28</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Melis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gessa]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids]]></article-title>
<source><![CDATA[Eur J Neurosci]]></source>
<year>1998</year>
<volume>10</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>2825-30</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bechara]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective]]></article-title>
<source><![CDATA[Nat Neurosci]]></source>
<year>2005</year>
<volume>8</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1458-63</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[MQ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis y psicopatología comorbida]]></article-title>
<source><![CDATA[Adicciones]]></source>
<year>2002</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>191-200</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salgado Carreño]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
</person-group>
<source><![CDATA[Revisión sistemática de los procesos neuropsicológicos afectados en adolescentes y adultos consumidores de marihuana. 2017]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Cooperativa de Colombia]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
